Rachel M. Carnes

Rachel Carnes is a seasoned executive in the pharmaceutical industry, currently serving as Senior Vice President of Global Product Strategy at Ionis Pharmaceuticals, Inc. since September 2022. Prior to this role, Rachel operated as Principal and Consultant at Rachel Carnes Consulting, focusing on strategy development for small biotech firms in hematology and oncology. Rachel was Vice President of Commercial for Early Hematology Assets at Bristol-Myers Squibb, managing a diverse portfolio of products. Rachel's extensive experience includes leadership positions at Celgene, where significant contributions were made in early commercialization strategies for multiple myeloma and epigenetics, as well as pivotal global marketing efforts for Abraxane. Early career experience includes roles at Aventis Pharmaceuticals. Rachel holds a Bachelor of Science in Nursing from the University of Sydney and a Diploma of Applied Science in Nursing from the University of Technology Sydney.